Customized research for BIOC vs. ACRX!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for BIOC vs. ACRX.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Biocept, Inc. vs. AcelRx Pharmaceuticals, Inc.

Industry Match! Industry of Both BIOC and ACRX:

Health Care/Life Sciences

BIOC
Data Last Updated: 23 hours ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 57.029M


P/E: N/A

P/S: 10.31

Q P/B: 2.51

Y Rev: 5.53M

Q Rev: 1.45M

Beta: 0.63

BIOC Share Stats

Outstanding Shares

131.10M

Float Shares

131.06M

Percent of Float Short

0.76%

BIOC Insider Stats

Percent Outstanding Insider Ownership

0.42%

Percent Outstanding Institution Ownership

2.7%

BIOC Social Stats

Followers

3

B/S Rating Today

0

B/S Rating All-Time

+3

More Social Data

BIOC in Pulse Portal

Stream of Posts

BIOC Symbol Page

Share BIOC Insights

Express Sentiment

'Buy' or 'Sell' BIOC

BIOC Profile

CEO

Mr. Michael W. Nall

Exchange

Nasdaq

Employees

88.00

About

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell...

BIOC Financials

Annual Financials

Income Statement

Revenue

5.53M

Net Income

(25.14M)

Cash Flow Statement

Change in Cash / Investments

5.88M

Balance Sheet

Cash / Investments

9.3M

Short Term Debt

842,452

Long Term Debt

None

Total Current Assets

13.89M

Total Current Liabilities

5.56M

Total Assets

17.73M

Total Liabilities

6.53M

Stockholder Equity

11.2M

Quarterly Financials

Income Statement

Q Revenue

1.45M

Q Net Income

(8.34M)

Cash Flow Statement

Q Change in Cash / Investments

12.19M

Balance Sheet

Q Cash / Investments

21.49M

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

26.26M

Q Total Current Liabilities

6.03M

Q Total Assets

29.81M

Q Total Liabilities

7.08M

Q Stockholder Equity

22.73M

BIOC Charts

10-Year Chart

BIOC 10-Year Chart

5-Year Chart

BIOC 5-Year Chart

1-Year Chart

BIOC 1-Year Chart

6-Month Chart

BIOC 6-Month Chart

3-Month Chart

BIOC 3-Month Chart

1-Month Chart

BIOC 1-Month Chart

1-Day Chart

BIOC 1-Day Chart

ACRX
Data Last Updated: 2 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 112.262M


P/E: N/A

P/S: 49.02

Q P/B: N/A

Y Rev: 2.29M

Q Rev: 386,000

Beta: 1.83

ACRX Share Stats

Outstanding Shares

80.42M

Float Shares

79.18M

Percent of Float Short

14.40%

ACRX Insider Stats

Percent Outstanding Insider Ownership

2.96%

Percent Outstanding Institution Ownership

18.62%

ACRX Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ACRX in Pulse Portal

Stream of Posts

ACRX Symbol Page

Share ACRX Insights

Express Sentiment

'Buy' or 'Sell' ACRX

ACRX Profile

CEO

Mr. Vincent J. Angotti

Exchange

Nasdaq

Employees

99.00

About

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce...

ACRX Financials

Annual Financials

Income Statement

Revenue

2.29M

Net Income

(53.24M)

Cash Flow Statement

Change in Cash / Investments

(73.29M)

Balance Sheet

Cash / Investments

66.14M

Short Term Debt

970,000

Long Term Debt

112.2M

Total Current Assets

71.69M

Total Current Liabilities

13.61M

Total Assets

91.36M

Total Liabilities

132.77M

Stockholder Equity

(41.42M)

Quarterly Financials

Income Statement

Q Revenue

386,000

Q Net Income

(15.93M)

Cash Flow Statement

Q Change in Cash / Investments

9.2M

Balance Sheet

Q Cash / Investments

52.73M

Q Short Term Debt

None

Q Long Term Debt

109.93M

Q Total Current Assets

58.05M

Q Total Current Liabilities

15.72M

Q Total Assets

77.34M

Q Total Liabilities

132.62M

Q Stockholder Equity

(55.28M)

ACRX Charts

10-Year Chart

ACRX 10-Year Chart

5-Year Chart

ACRX 5-Year Chart

1-Year Chart

ACRX 1-Year Chart

6-Month Chart

ACRX 6-Month Chart

3-Month Chart

ACRX 3-Month Chart

1-Month Chart

ACRX 1-Month Chart

1-Day Chart

ACRX 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon